{"cluster": 63, "subcluster": 17, "abstract_summ": " The pandemic of coronavirus disease 2019 (COVID-19) presents an unprecedented challenge to identify effective drugs for prevention and treatment . Remdesivir has potent in vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved and currently is being tested in ongoing randomized trials . We show some agents with potentially favorable efficacy, acceptable safety as well as good pharmacokinetic profiles ."}